Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Inflamm Bowel Dis ; 25(1): 134-141, 2019 01 01.
Article in English | MEDLINE | ID: mdl-29868777

ABSTRACT

Background: Infliximab (IFX) discontinuation is not uncommon during the first year of treatment due to inadequate drug concentrations and anti-IFX antibodies (ATI). Both combination therapy and proactive therapeutic drug monitoring (pTDM) are used to decrease ATI and increase IFX durability. We proposed that monotherapy (Mono) is as effective as combination therapy (Combo) if the first maintenance infusion is dosed based on week 10 pTDM. Methods: In a retrospective cohort of 83 patients with inflammatory bowel disease (IBD), we examined the frequency of IFX discontinuation, ATI, infusion reactions, and IFX concentrations during the first year of treatment in patients receiving week 10 pTDM-guided IFX monotherapy (Mono pTDM; n = 16) compared with patients on mono (n = 32) or combination therapy (n = 35) in whom TDM was introduced at or after week 14, per standard of care (SOC). Results: The frequency of IFX discontinuation was lower with Mono pTDM compared with Mono SOC (P = 0.04) but did not differ with Combo SOC (P = 1). At first TDM, no patient in the pTDM strategy had ATI, vs 41% in Mono SOC (P = 0.002) and 6% in Combo SOC (P = 1). Of the 13 subjects with ATI in Mono SOC, 7 (47%) had ATI already at week 14. IFX trough concentrations with Mono pTDM were higher during maintenance compared with Mono SOC (9.5 vs 6.4 µg/mL, P = 0.04) but not Combo SOC. Conclusions: Infliximab durability did not differ between patients on IFX monotherapy dosed based on p-TDM and patients receiving combination therapy. In the absence of concomitant immunosuppression, proactive TDM may improve IFX durability by maintaining higher IFX concentrations entering into maintenance. Further studies are needed to confirm our findings.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Colitis, Ulcerative/drug therapy , Crohn Disease/drug therapy , Drug Monitoring/standards , Gastrointestinal Agents/therapeutic use , Infliximab/therapeutic use , Adolescent , Child , Colitis, Ulcerative/pathology , Crohn Disease/pathology , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Male , Prognosis , Retrospective Studies , Survival Rate
2.
G3 (Bethesda) ; 7(12): 3867-3873, 2017 12 04.
Article in English | MEDLINE | ID: mdl-29021218

ABSTRACT

The dietary specialist fruit fly Drosophila sechellia has evolved to specialize on the toxic fruit of its host plant Morinda citrifolia Toxicity of Morinda fruit is primarily due to high levels of octanoic acid (OA). Using RNA interference (RNAi), prior work found that knockdown of Osiris family genes Osiris 6 (Osi6), Osi7, and Osi8 led to increased susceptibility to OA in adult D. melanogaster flies, likely representing genes underlying a Quantitative Trait Locus (QTL) for OA resistance in D. sechellia While genes in this major effect locus are beginning to be revealed, prior work has shown at least five regions of the genome contribute to OA resistance. Here, we identify new candidate OA resistance genes by performing differential gene expression analysis using RNA-sequencing (RNA-seq) on control and OA-exposed D. sechellia flies. We found 104 significantly differentially expressed genes with annotated orthologs in D. melanogaster, including six Osiris gene family members, consistent with previous functional studies and gene expression analyses. Gene ontology (GO) term enrichment showed significant enrichment for cuticle development in upregulated genes and significant enrichment of immune and defense responses in downregulated genes, suggesting important aspects of the physiology of D. sechellia that may play a role in OA resistance. In addition, we identified five candidate OA resistance genes that potentially underlie QTL peaks outside of the major effect region, representing promising new candidate genes for future functional studies.


Subject(s)
Caprylates/chemistry , Drosophila melanogaster/genetics , Morinda/chemistry , Receptors, Odorant/genetics , Animals , Caprylates/toxicity , Drosophila melanogaster/drug effects , Gene Expression Profiling/methods , Gene Expression Regulation/drug effects , Morinda/toxicity , Quantitative Trait Loci/genetics , RNA Interference , Sequence Analysis, RNA , Species Specificity , Transcriptome/drug effects , Transcriptome/genetics
3.
Inflamm Bowel Dis ; 23(3): 341-346, 2017 03.
Article in English | MEDLINE | ID: mdl-28178002

ABSTRACT

BACKGROUND: Adolescence is a vulnerable period for those afflicted with inflammatory bowel disease (IBD). There is limited knowledge of factors influencing transition readiness in this population. We sought to determine whether self-efficacy and resilience would be informative predictors of transition readiness independent of age. METHODS: Patients with IBD aged 16 to 23 years cared for in a pediatric setting were prospectively enrolled. On entry, patients filled out the Transition Readiness Assessment Questionnaire (TRAQ); IBD Self-Efficacy Scale-Adolescent (IBD-SES-A); and the Connor-Davidson Resilience Scale. Demographic data and disease-specific information were collected from the medical record and by the provider. General linear modeling and autocorrelation were performed to investigate predictors of transition readiness. RESULTS: Eighty-seven patients (62 Crohn's disease and 25 ulcerative colitis) were included, with a median age of 19 years (interquartile range 1-3: 17-20; min-max: 16-23). After controlling for age, the IBD-SES-A predicted TRAQ [F(1) = 11.69, R = 0.16, P = 0.001], accounting for 16% of the variance. The Connor-Davidson Resilience Scale also independently predicted TRAQ score [F(1) = 6.45, R = 0.09, P = 0.01], accounting for 9% of the variance. The IBD-SES-A and Connor-Davidson Resilience Scale were significantly auto correlated (r = 0.044, P = 0.001); in the final predictive model, only IBD-SES-A was predictive of TRAQ [F(1) = 4.01, R = 0.12, P = 0.004]. None of the patients' demographic, disease, or socioeconomic parameters informed transition readiness once self-efficacy and resilience were considered. CONCLUSIONS: This is the first study to identify a reliable predictor of transition readiness scores in adolescents with IBD that does not seem to be influenced by age.


Subject(s)
Colitis, Ulcerative/psychology , Crohn Disease/psychology , Resilience, Psychological , Self Efficacy , Transition to Adult Care , Adolescent , Female , Humans , Linear Models , Male , Surveys and Questionnaires , Young Adult
4.
Ear Hear ; 37(1): 1-13, 2016.
Article in English | MEDLINE | ID: mdl-26372266

ABSTRACT

OBJECTIVES: The purpose of this study was to investigate the effects of background noise and reverberation on listening effort. Four specific research questions were addressed related to listening effort: (A) With comparable word recognition performance across levels of reverberation, what are the effects of noise and reverberation on listening effort? (B) What is the effect of background noise when reverberation time is constant? (C) What is the effect of increasing reverberation from low to moderate when signal to noise ratio is constant? (D) What is the effect of increasing reverberation from moderate to high when signal to noise ratio is constant? DESIGN: Eighteen young adults (mean age 24.8 years) with normal hearing participated. A dual-task paradigm was used to simultaneously assess word recognition and listening effort. The primary task was monosyllable word recognition, and the secondary task was word categorization (press a button if the word heard was judged to be a noun). Participants were tested in quiet and in background noise in three levels of reverberation (T30 < 100 ms, T30 = 475 ms, and T30 = 834 ms). Signal to noise ratios used were chosen individually for each participant and varied by reverberation to address the specific research questions. RESULTS: As expected, word recognition performance was negatively affected by both background noise and by increases in reverberation. Furthermore, analysis of mean response times revealed that background noise increased listening effort, regardless of degree of reverberation. Conversely, reverberation did not affect listening effort, regardless of whether word recognition performance was comparable or signal to noise ratio was constant. CONCLUSIONS: The finding that reverberation did not affect listening effort, even when word recognition performance was degraded, is inconsistent with current models of listening effort. The reasons for this surprising finding are unclear and warrant further investigation. However, the results of this study are limited in generalizability to young listeners with normal hearing and to the signal to noise ratios, loudspeaker to listener distance, and reverberation times evaluated. Other populations, like children, older listeners, and listeners with hearing loss, have been previously shown to be more sensitive to reverberation. Therefore, the effects of reverberation for these vulnerable populations also warrant further investigation.


Subject(s)
Noise , Signal-To-Noise Ratio , Speech Perception/physiology , Task Performance and Analysis , Adult , Auditory Perception/physiology , Female , Healthy Volunteers , Hearing/physiology , Humans , Male , Reaction Time , Young Adult
5.
J Pediatr Gastroenterol Nutr ; 62(5): 711-4, 2016 05.
Article in English | MEDLINE | ID: mdl-26655944

ABSTRACT

OBJECTIVES: Epstein Barr virus (EBV) is a human herpes virus that infects 90% of the world's population and has been linked to the development of lymphoproliferative disorders (LPDs) and immunosuppression. Primary EBV infection in patients with IBD on thiopurines is a risk factor for LPD, including lymphoma. We aimed to describe EBV status in a pediatric population with IBD with an emphasis on those initiating thiopurines. METHODS: Electronic medical records and EBV serologies were reviewed and categorized into asymptomatic screening versus suspicion for acute infection. EBV status before therapy was described by sex, age, and therapeutic regimen. Descriptive statistics and univariate analysis were employed. RESULTS: Only 150 (22%) of our 688 pediatric patients with IBD had documented EBV status regardless of age or treatment regimen. Only 17% were assessed for suspicion of acute infection and 83% for screening. Sixty-four (52%) screened patients were checked before starting any treatment and only 40% were immunoglobulin (Ig)G positive. There was no difference in mean age between the seronegative and seropositive group. The majority (63%) of thiopurine-treated patients were IgG negative before starting therapy. Eighty percent of primary EBV infections occurred on thiopurines at a mean (SD) of 2 ±â€Š1.5 years after initiating therapy. CONCLUSIONS: The majority of our pediatric patients with IBD with documented EBV status were IgG negative at thiopurine initiation. Thiopurines were also associated with primary EBV infection. EBV status may be an important determinate of whether physicians prescribe thiopurines given the risk of primary EBV infections and lymphoproliferative diseases.


Subject(s)
Epstein-Barr Virus Infections/diagnosis , Herpesvirus 4, Human/isolation & purification , Immunosuppressive Agents/therapeutic use , Inflammatory Bowel Diseases/epidemiology , Lymphoma/diagnosis , Mercaptopurine/therapeutic use , Adolescent , Child , Cross-Sectional Studies , Female , Humans , Immunosuppressive Agents/adverse effects , Inflammatory Bowel Diseases/complications , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/virology , Lymphoma/etiology , Male , Mercaptopurine/adverse effects , New York City/epidemiology , Retrospective Studies , Viral Load , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...